Spirit Scientific Co

Spirit Scientific Co Net Margin

The Net Profit Margin of Spirit Scientific Co (7790.TWO) as of Oct 30, 2026 is 2.23 %. In the previous year, Net Profit Margin was 2.82 % — a change of -20.84% (lower).

Net Margin

2.23 %

YoY

-20.84%

Last updated:

Net Profit Margin of Spirit Scientific Co is 2024 2.23 % . Net Profit Margin of Spirit Scientific Co was 2023 2.82 % . It decreases by -20.84% lower compared to the previous year.

Spirit Scientific Co's net margin stands at 2.2%, down from 4.9% several years earlier.

The Spirit Scientific Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2022
4.89 TWD
Jan 1, 2023
2.82 TWD
Jan 1, 2024
2.23 TWD
The Spirit Scientific Co Net Margin history
YEARNet MarginYoY
2.23 %-20.84%
2.82 %-42.36%
4.89 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Spirit Scientific Co Stock analysis

What does Spirit Scientific Co do? Spirit Scientific Co Ltd generates revenue through autologous Platelet Lyophilized Technology (PLT) cryo-crystal preparation services and autologous high-concentration platelet gel preparation services. The company also offers clinical research cooperation commission services, blood-related commissioned manufacturing, biomaterial-type cryo-crystal testing or commissioned manufacturing, biomaterial-type cosmetic raw material production, and biomaterial-type cryo-crystal laboratory construction consulting services. These services are primarily sold to healthcare providers and research institutions within Taiwan, focusing on biomaterial separation, purification, mass production, and standardized process development for biotechnology applications. The firm's main products target the health care equipment and supplies industry, with a strong emphasis on growth factor cryo-crystal related solutions. Their services are tailored to meet the needs of clients seeking advanced biotechnology services, including the development of biomaterial-type cryo-crystals and cosmetic raw materials. Spirit Scientific operates exclusively in Taiwan, serving local healthcare and research sectors with specialized biotechnology offerings. Revenue streams include both service-based contracts for cryo-crystal preparation and manufacturing, as well as consulting services for laboratory construction. The company’s focus on biomaterial separation, purification, and dosage form improvement drives demand from clients requiring standardized biotechnology processes. All services are delivered within Taiwan, aligning with the firm's exclusive market presence. Spirit Scientific Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Spirit Scientific Co stock

Net Profit Margin of Spirit Scientific Co is 2.23 % in 2024.

Net Profit Margin of Spirit Scientific Co changed from 2.82 % to 2.23 %, representing a -20.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Spirit Scientific Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Spirit Scientific Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Spirit Scientific Co

All Key Metrics — Spirit Scientific Co